Evaluating Alcohol Use in Alcoholic Liver Disease
Launched by NICOLE T SHEN · Aug 28, 2017
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how alcohol use affects people with alcoholic liver disease, a condition that can damage the liver due to heavy drinking. The study aims to understand if patients who have this disease continue to drink alcohol after treatment, which is important for improving their care and recovery. Adults between the ages of 65 and 74 who have been diagnosed with alcoholic liver disease and are able to give their consent to participate may be eligible to join the trial.
Participants in this study can expect to share their experiences and medical information related to their alcohol use and liver health. The trial is currently recruiting, meaning that it is still looking for people to take part. It's important for potential participants to know that those without alcoholic liver disease or those who cannot give consent will not be included in the study. This research aims to find better ways to support patients in managing their health and reducing alcohol use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • alcoholic liver disease able to consent
- Exclusion Criteria:
- • without alcoholic liver disease unable to consent
About Nicole T Shen
Nicole T. Shen is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong background in clinical development and regulatory affairs, she fosters collaborations that bridge innovative therapeutic solutions with rigorous scientific standards. Her leadership emphasizes ethical practices, patient safety, and data integrity, ensuring that each trial is conducted with the utmost professionalism. By leveraging her expertise and a network of industry partnerships, Nicole T. Shen aims to facilitate groundbreaking studies that contribute to the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Robert S Brown, MD, MPH
Principal Investigator
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials